Please use this identifier to cite or link to this item:
Title: Cardio-oncology. Editorial on: Management and Outcomes of Patients with Atrial Fibrillation and a History of Cancer: The ORBIT-AF registry
Authors: Adlam, D.
Peake, M.
First Published: 21-Feb-2017
Publisher: Oxford University Press (OUP)
Citation: European Heart Journal - Quality of Care and Clinical Outcomes, 2017,
Abstract: [First paragraph] Clinical medicine and medical research have long occupied disease-specific specialties. A visitor to any hospital or university in a developed country will likely find a cardiology department or an institute of cancer research but frequently these are widely separated or even in different buildings. This is reflected in clinical research where cancer is a frequent exclusion criteria from cardiovascular trials and likewise patients with established heart disease are often routinely excluded from cancer studies. As a result our understanding of how cancer, cardiovascular disease and their treatments interact remains relatively limited. This is despite the fact that improved treatments for both conditions have resulted in substantially improved survival rates and as a result, an ever larger population of patients will now experience both conditions in their lifetime.
DOI Link: 10.1093/ehjqcco/qcx002
ISSN: 2058-5225
eISSN: 2058-1742
Version: Post-print
Status: Peer-reviewed
Type: Journal Article
Rights: Copyright © 2017, Oxford University Press (OUP). Deposited with reference to the publisher’s open access archiving policy.
Description: The file associated with this record is under embargo until 12 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.
Appears in Collections:Published Articles, Dept. of Cardiovascular Sciences

Files in This Item:
File Description SizeFormat 
Editorial4_MP comments.pdfPost-review (final submitted author manuscript)579.39 kBAdobe PDFView/Open

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.